Aptevo Therapeutics Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $726.00K, a 94.95% decline year-over-year.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $872.00K.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $18.34M, a 313.34% increase year-over-year.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $14.36M, a 261.81% increase year-over-year.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for fiscal 2025 was $38.50M, a 302.52% increase from fiscal 2024.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for fiscal 2024 was $9.56M, a 48.79% increase from fiscal 2023.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for fiscal 2023 was $6.43M, a 7.30% decline from fiscal 2022.
- Aptevo Therapeutics Inc. stock issued during period, value, new issues for fiscal 2022 was $6.93M, a 32.25% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $726.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $872.00K 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $38.50M 10-K · filed 2026-03-26 | |
| 2025-09-30 | $18.34M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $14.36M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $9.56M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $4.44M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $3.97M 10-Q · filed 2025-11-06 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $6.43M 10-K · filed 2025-02-14 | |
| 2023-09-30 | $1.20M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $482.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $1.60M 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $6.93M 10-K · filed 2024-03-05 | |
| 2022-06-30 | $436.00K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $10.23M 10-K · filed 2023-03-30 | |
| 2021-06-30 | $10.23M 10-Q · filed 2022-11-10 | |
| 2019-09-30 | $136.00K 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |